mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.8 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |